Loading clinical trials...
Loading clinical trials...
A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors
Conditions
Interventions
ZL-1310
Locations
20
United States
Zai Lab Site 2001
San Francisco, California, United States
Zai Lab Site 2013
Detroit, Michigan, United States
Zai Lab Site 2002
New York, New York, United States
Zai Lab Site 2024
Cleveland, Ohio, United States
Zai Lab Site 2004
Philadelphia, Pennsylvania, United States
Zai Lab Site 2014
Nashville, Tennessee, United States
Start Date
May 12, 2025
Primary Completion Date
August 1, 2027
Completion Date
December 1, 2027
Last Updated
April 9, 2026
NCT07489378
NCT07181681
NCT07360314
NCT07204340
NCT07403721
NCT06721689
Lead Sponsor
Zai Lab (Shanghai) Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions